Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Bifidobacterium breve BR03 and Bifidobacterium breve B632
DRUG
2 trials
Sponsors
Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions
Bifidobacterium Breve
Colic, Infantile
Gut Microbiome
Obesity, Childhood
Probiotic
Phase 4
NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants
Completed
NCT03219931
Azienda Ospedaliero Universitaria Maggiore della Carita
Bifidobacterium Breve, Colic, Infantile, Gut Microbiome +1
Start: 2013-10-01
End: 2017-07-31
Updated: 2018-01-11
BIFI-OBESE: Clinical Trial in Paediatric Obesity
Completed
NCT03261466
Azienda Ospedaliero Universitaria Maggiore della Carita
Obesity, Childhood
Start: 2013-11-20
End: 2017-10-30
Updated: 2018-01-11
Related Papers
Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial.
2021-06-11
61 citations